Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes

Regulatory Peptides

Volumn 137, Issue 1-2, 2006, Pages 75-78

  Goetzl, Edward J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

G proteins; Immune system; Inflammation; Neuroendocrine peptide; Nuclear receptor

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; EFFECTOR CELL; HUMAN; LYMPHOCYTE FUNCTION; NEUROIMMUNOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

CELL MEMBRANE; NUCLEAR ENVELOPE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33751063779     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.04.022     Document Type: Review

References (21)

1. Gomariz R.P., Leceta J., Garrido E., Garrido T., and Delgado M. Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes. Regul Pept 50 (1994) 177-184
2. Martinez C., Delgado M., Abad C., Gomariz R.P., Ganea D., and Leceta J. Regulation of VIP production and secretion by murine lymphocytes. J Neuroimmunol 93 (1999) 126-138
3. Delgado M., and Ganea D. Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?. J Immunol 166 (2001) 2907-2912
4. Delgado M., Martinez C., Johnson M.C., Gomariz R.P., and Ganea D. Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. J Neuroimmunol 68 (1996) 27-38
5. Johnson M.C., McCormack R.J., Delgado M., Martinez C., and Ganea D. Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA. J Neuroimmunol 68 (1996) 109-119
6. Metwali A., Blum A.M., Li J., Elliott D.E., and Weinstock J.V. IL-4 regulates VIP receptor subtype 2 mRNA (VPAC2) expression in T cells in murine schistosomiasis. FASEB J 14 (2000) 948-954
7. Lara-Marquez M., O'Dorisio M., O'Dorisio T., Shah M., and Karacay B. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J Immunol 166 (2001) 2522-2530
8. Dorsam G., Voice J., Kong Y., and Goetzl E.J. Vasoactive intestinal peptide mediation of development and functions of T lymphocytes. Ann N Y Acad Sci 921 (2000) 79-91
9. Delgado M., Pozo D., and Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56 (2004) 249-290
10. Grinninger C., Wang W., Oskoui K.B., Voice J.K., and Goetzl E.J. A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function. J Biol Chem 279 (2004) 40259-40262
11. Gobeil Jr. F., Berniera S.G., Vazquez-Tello A., Brault S., Beauchamp M.H., Quiniou C., et al. Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 278 (2003) 38875-38883
12. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5 (2005) 560-570
13. Merjan A.J., Kanashiro C.A., Krieger J.E., Han S.W., and Paiva A.C. Ligand-induced endocytosis and nuclear localization of angiotensin II receptors expressed in CHO cells. Braz J Med Biol Res 34 (2001) 1175-1183
14. Peng H., Moffett J., Myers J., Fang X., Stachowiak E.K., Maher P., et al. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell 12 (2001) 449-462
15. Faucheux C., Horton M.A., and Price J.S. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. J Bone Miner Res 17 (2002) 455-464
16. Licea H., Walters M.R., and Navar L.G. Renal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol Hung 89 (2002) 427-438
17. Menzies J., Paul A., and Kennedy C. P2X7 subunit-like immunoreactivity in the nucleus of visceral smooth muscle cells of the guinea pig. Auton Neurosci 106 (2003) 103-109
18. Lee D.K., Lanca A.J., Cheng R., Nguyen T., Ji X.D., Gobeil Jr. F., et al. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 279 (2004) 7901-7908
19. Toy-Miou-Leong M., Cortes C.L., Beaudet A., Rostene W., and Forgez P. Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation. J Biol Chem 279 (2004) 12636-12646
20. Nielsen C.K., Campbell J.I., Ohd J.F., Morgelin M., Riesbeck K., Landberg G., et al. A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 65 (2005) 732-742
21. Gobeil Jr. F., Zhu T., Brault S., Geha A., Vazquez-Tello A., Fortier A., et al. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes i-NOS and mPGES-1. J Biol Chem 281 (2006) 16058-16067